Literature DB >> 30670880

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

David L Veenstra1,2, Jonathan S Berg3, Robert C Green4,5,6,7, Leslie G Biesecker8, Lucia A Hindorff9, M Ragan Hart10,11, Barbara B Biesecker12, Carrie L Blout4, Kurt D Christensen4,5, Laura M Amendola13,1, Katie L Bergstrom14, Sawona Biswas15, Kevin M Bowling16, Kyle B Brothers17, Laura K Conlin18,19, Greg M Cooper16, Matthew C Dulik18,19, Kelly M East16, Jessica N Everett20,21, Candice R Finnila16, Arezou A Ghazani22, Marian J Gilmore23, Katrina A B Goddard24, Gail P Jarvik13,1, Jennifer J Johnston8, Tia L Kauffman24, Whitley V Kelley16, Joel B Krier4, Katie L Lewis8, Amy L McGuire25, Carmit McMullen24, Jeffrey Ou1, Sharon E Plon14, Heidi L Rehm5,26,6, C Sue Richards27, Edward J Romasko18, Ane Miren Sagardia12, Nancy B Spinner18, Michelle L Thompson16, Erin Turbitt12, Jason L Vassy4,5,28, Benjamin S Wilfond29.   

Abstract

The originally published version of this Article contained errors in Fig. 2. The numbers below the black arrowheads were incorrect; please see incorrect Figure in associated Correction. These errors have now been corrected in the PDF and HTML versions of the Article.

Entities:  

Year:  2019        PMID: 30670880     DOI: 10.1038/s41436-019-0440-2

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  1 in total

1.  Management of significant secondary genetic findings in an ophthalmic genetics clinic.

Authors:  Julia Zhu; Kirk A J Stephenson; G Jane Farrar; Jacqueline Turner; James J O'Byrne; David Keegan
Journal:  Eye (Lond)       Date:  2021-05-03       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.